1. Fais F., Ghiotto F., Hashimoto S., Sellars B., Valetto A., Allen S.L. et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors // J. Clin. Invest. 1998. Vol. 102. P. 1515–1525.
2. Johnson T.A., Rassenti L.Z., Kipps T.J. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features // J. Immunol. 1997. Vol. 158. P. 235–246.
3. Schroeder H.W. Jr, Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire // Immunol. Today. 1994. Vol. 15. P. 288–294.
4. Hashimoto S., Dono M., Wakai M., Allen S.L., Lichtman S.M., Schulman P. et al. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells // J. Exp. Med. 1995. Vol. 181. P. 1507–1517.
5. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L. et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia // Blood. 1999. Vol. 94. P. 1840–1847.
6. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., Stevenson F.K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia // Blood. 1999. Vol. 94. P. 1848–1854.
7. Vardi A., Agathangelidis A., Sutton L.A., Ghia P., Rosenquist R., Stamatopoulos K. Immunogenetic studies of chronic lymphocytic leukemia: revelations and speculations about ontogeny and clinical evolution // Cancer Res. 2014. Vol. 74. P. 4211–4216.
8. Burger J.A., Chiorazzi N. B cell receptor signaling in chronic lymphocytic leukemia // Trends Immunol. 2013. Vol. 34. P. 592–601.
9. Packham G., Krysov S., Allen A., Savelyeva N., Steele A.J., Forconi F. et al. The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy // Haematologica. 2014. Vol. 99. P. 1138–1148.
10. Sutton L.A., Rosenquist R. The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia // Semin. Cancer Biol. 2015. Vol. 34. P. 22–35.
11. Agathangelidis A., Darzentas N., Hadzidimitriou A., Brochet X., Murray F., Yan X.J. et al. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies // Blood. 2012. Vol. 119. P. 4467–4475.
12. Messmer B.T., Albesiano E., Efremov D.G., Ghiotto F., Allen S.L., Kolitz J. et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia // J. Exp. Med. 2004. Vol. 200. P. 519–525.
13. Stamatopoulos K., Belessi C., Moreno C., Boudjograh M., Guida G., Smilevska T. et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations // Blood. 2007. Vol. 109. P. 259–270.
14. Gounari M., Ntoufa S., Apollonio B., Papakonstantinou N., Ponzoni M., Chu C.C. et al. Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8 // Blood. 2015. Vol. 125. P. 3580–3587.
15. Ntoufa S., Papakonstantinou N., Apollonio B., Gounari M., Galigalidou C., Fonte E. et al. B cell anergy modulated by TLR1/2 and the miR-17 approximately 92 cluster underlies the indolent clinical course of chronic lymphocytic leukemia stereotyped subset #4 // J. Immunol. 2016. Vol. 196. P. 4410–4417.
16. Mansouri L., Sutton L.A., Ljungstrom V., Bondza S., Arngarden L., Bhoi S. et al. Functional loss of IkappaBepsilon leads to NF-kappaB deregulation in aggressive chronic lymphocytic leukemia // J. Exp. Med. 2015. Vol. 212. P. 833–843.
17. Navrkalova V., Young E., Baliakas P., Radova L., Sutton L.A., Plevova K. et al. ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres // Haematologica. 2016. Vol. 101. P. e369–e373.
18. Rossi D., Spina V., Bomben R., Rasi S., Dal-Bo M., Bruscaggin A. et al. Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia // Blood. 2013. Vol. 121. P. 4902–4905.
19. Sutton L.A., Young E., Baliakas P., Hadzidimitriou A., Moysiadis T., Plevova K. et al. Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors // Haematologica. 2016. Vol. 101. P. 959–967.
20. Baliakas P., Hadzidimitriou A., Sutton L.A., Minga E., Agathangelidis A., Nichelatti M. et al. Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study // Lancet Haematol. 2014. Vol. 1. P. e74–e84.
21. Stamatopoulos K., Agathangelidis A., Rosenquist R., Ghia P. Antigen receptor stereotypy in chronic lymphocytic leukemia // Leukemia. 2017. Vol. 31. P. 282–291.
22. Strefford J.C., Sutton L.A., Baliakas P., Agathangelidis A., Malcikova J., Plevova K. et al. Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2 // Leukemia. 2013. Vol. 27. P. 2196–2199.
23. Baliakas P., Agathangelidis A., Hadzidimitriou A., Sutton L.A., Minga E., Tsanousa A. et al. Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations // Blood. 2015. Vol. 125. P. 856–859.
24. Fischer K., Bahlo J., Fink A.M., Goede V., Herling C.D., Cramer P. et al. Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial // Blood. 2016. Vol. 127. P. 208–215.
25. Rossi D., Terzi-di-Bergamo L., De Paoli L., Cerri M., Ghilardi G., Chiarenza A. et al. Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia // Blood. 2015. Vol. 126. P. 1921–1924.